Surging prevalence of chronic cardiovascular diseases is likely to spur interventional cardiology & peripheral vascular devices market size through forthcoming years. Rising research and development activities towards the development of advanced solutions by government as well as private vascular device companies is further set to escalate global interventional cardiology devices market growth.

As per the latest study by Global Market Insights, Inc., interventional cardiology and peripheral vascular devices market is estimated to surpass USD 32.5 billion by 2026. This rise is primarily attributed to increase in technological contributions by prominent peripheral vascular device companies comprising Abbott Laboratories, C. R. Bard, Cardinal Health, Medtronic, AngioDynamics, Cook Medical, and others.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/1964  

Considering an instance of such developments, Boston Scientific has developed its Ranger Drug-coated Balloon for the treatment of patients having PAD (peripheral artery disease) in the proximal popliteal artery (PPA) and superficial femoral artery (SFA). The product has recently received the approval of the U.S. Food and Drug Administration and is considered to be a plausible relief for around 200 million people affected by peripheral artery disease.

Additionally, Boston Scientific has also shared plans for the commencement of a registry for its Eluvia stent and the Ranger DCB over ensuing months. The move intends to garner additional real-world evidence, that is expected to add to the repository of clinical data gathered on these devices till date. Similar advancements are likely to augment industry growth over the projected period.

Surging severe vascular conditions creating a rise in the number of hospital admissions is likely to escalate the contribution of hospitals segment through the anticipated period. Hospitals segment held an appreciable share of 86 per cent of the overall interventional cardiology & peripheral vascular devices industry size in 2019.

Request for customization @ https://www.decresearch.com/roc/1964

Presence of highly skilled professionals in hospitals coupled with increased adoption of advanced medical devices for interventional cardiology is set to propel segment growth given the increasing preference by patients for these settings.

Inclusive valvuloplasty applications in the narrowing of mitral valve and pulmonary valve as well as in severe valve narrowing will impel valvuloplasty revenue share through 2026.  

As per the Centers for Disease Control and Prevention, nearly 13 per cent of people suffer from valvular heart disease, creating prospects for fostering the growth of valvuloplasty market in interventional cardiology & peripheral devices industry through coming years. Valvuloplasty segment held a remarkable share of more than USD 1.5 billion in 2019.

North America interventional cardiology & peripheral vascular devices market contributed a valuation of more than USD 5 billion in 2019. Coronary heart diseases have been the chief cause of over 300,000 deaths in the United States in 2017, according to the Centers for Disease Control and Prevention.

Minimization of the escalating disease burden contributing to the development of efficient solutions by prominent players has been imperative in boosting peripheral vascular device business prospects in the region.

In essence, escalating demand for peripheral vascular medical devices in interventional cardiology procedures owing to applications in the treatment of peripheral diseases will bolster industry expansion in the coming years. Rising geriatric population leading to increased disease burden will further propel the growth of interventional cardiology & peripheral vascular devices industry through the estimated period.

Partial Chapter of the Table of Content

Chapter 2. Executive Summary

2.1. Interventional cardiology & peripheral vascular devices industry 360° synopsis, 2015 – 2026

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Application trends

2.1.4.  End-use trends

2.1.5.  Regional trends

Chapter 3. Interventional Cardiology & Peripheral Vascular Devices Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.   Growing prevalence of vascular diseases worldwide

3.3.1.2.   Technological advancements in peripheral vascular devices

3.3.1.3.   Rising adoption of minimally invasive procedures

3.3.1.4.   Increasing government spending pertaining to cardiovascular diseases burden

3.3.2.  Industry pitfalls and challenges

3.3.2.1.   Stringent regulatory framework

3.3.2.2.   Post-procedural complications associated with devices

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By application

3.4.3.  By end-use

3.5. COVID-19 impact analysis

3.6. Porter’s analysis

3.7. Company landscape, 2019

3.8. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/interventional-cardiology-and-peripheral-vascular-devices-market